Phase 2 Readout
CABA: Phase 2 Readout: rese-cel
June 30, 2027 · rese-cel. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- June 30, 2027
- Company
- Cabaletta Bio, Inc. (CABA)
- Drug
- rese-cel
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: rese-cel
- Company
- Cabaletta Bio, Inc. (CABA)
- Drug
- rese-cel
- Indication
- dermatomyositis/antisynthetase syndrome